BR0010213A - Derivados de ciclocarbamato como moduladores de receptor de progesterona - Google Patents

Derivados de ciclocarbamato como moduladores de receptor de progesterona

Info

Publication number
BR0010213A
BR0010213A BR0010213-0A BR0010213A BR0010213A BR 0010213 A BR0010213 A BR 0010213A BR 0010213 A BR0010213 A BR 0010213A BR 0010213 A BR0010213 A BR 0010213A
Authority
BR
Brazil
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
BR0010213-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Andrew Fensome
Puwen Zhang
Eugene A Terefenko
Horace Fletcher Iii
Jay E Wrobel
Lin Zhi
Todd K Jones
Christopher M Tegley
James P Edwards
Original Assignee
American Home Prod
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,633 external-priority patent/US6509334B1/en
Application filed by American Home Prod, Ligand Pharm Inc filed Critical American Home Prod
Publication of BR0010213A publication Critical patent/BR0010213A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR0010213-0A 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona BR0010213A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301299P 1999-05-04 1999-05-04
US09/552,633 US6509334B1 (en) 1999-05-04 2000-04-19 Cyclocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011822 WO2000066571A1 (en) 1999-05-04 2000-05-01 Cyclocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
BR0010213A true BR0010213A (pt) 2002-02-19

Family

ID=26878647

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0010213-0A BR0010213A (pt) 1999-05-04 2000-05-01 Derivados de ciclocarbamato como moduladores de receptor de progesterona

Country Status (19)

Country Link
EP (1) EP1173426A1 (tr)
JP (1) JP2002543193A (tr)
KR (1) KR20010114250A (tr)
CN (1) CN1145618C (tr)
AU (1) AU766428B2 (tr)
BG (1) BG106079A (tr)
BR (1) BR0010213A (tr)
CA (1) CA2371726A1 (tr)
CZ (1) CZ20013951A3 (tr)
EA (1) EA004512B1 (tr)
HU (1) HUP0201609A3 (tr)
IL (1) IL146280A0 (tr)
MX (1) MXPA01011286A (tr)
NO (1) NO321361B1 (tr)
NZ (1) NZ515355A (tr)
PL (1) PL351127A1 (tr)
SG (1) SG114650A1 (tr)
SK (1) SK15912001A3 (tr)
TR (1) TR200103286T2 (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5108506B2 (ja) * 2004-04-27 2012-12-26 ワイス・エルエルシー シアノピロール含有環式カルバメートおよびチオカルバメートビアリール、およびこれらの製造方法
EP1844768A1 (en) * 2005-01-19 2007-10-17 Dainippon Sumitomo Pharma Co., Ltd. Aromatic sulfone compound as aldosterone receptor modulator
US8314094B2 (en) 2007-10-05 2012-11-20 Msd K.K Benzoxazinone derivative
CN111925353B (zh) * 2020-08-31 2022-04-08 苏州大学附属第二医院 一种2-噻吩甲腈的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
WO1995020389A1 (en) * 1994-01-28 1995-08-03 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
EP1043326A1 (en) * 1994-12-22 2000-10-11 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
CA2268953A1 (en) * 1996-10-02 1998-04-09 Du Pont Pharmaceuticals Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same

Also Published As

Publication number Publication date
EA004512B1 (ru) 2004-04-29
NO20015378D0 (no) 2001-11-02
AU4688600A (en) 2000-11-17
KR20010114250A (ko) 2001-12-31
JP2002543193A (ja) 2002-12-17
IL146280A0 (en) 2002-07-25
TR200103286T2 (tr) 2002-07-22
HUP0201609A3 (en) 2002-12-28
CA2371726A1 (en) 2000-11-09
NO20015378L (no) 2002-01-03
SK15912001A3 (sk) 2002-06-04
SG114650A1 (en) 2005-09-28
MXPA01011286A (es) 2003-07-14
NZ515355A (en) 2004-02-27
CN1349517A (zh) 2002-05-15
NO321361B1 (no) 2006-05-02
CZ20013951A3 (cs) 2002-05-15
AU766428B2 (en) 2003-10-16
HUP0201609A2 (en) 2002-08-28
BG106079A (en) 2002-05-31
PL351127A1 (en) 2003-03-24
CN1145618C (zh) 2004-04-14
EP1173426A1 (en) 2002-01-23
EA200101176A1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
HUP0301069A2 (hu) Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NO20070336L (no) Indolderivater som histamin-reseptorantagonister
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
BR0306208A (pt) Compostos de dibenzilamina e seu uso farmacêutico
NO20004778L (no) Amidderivater og nociceptin antagonister
BRPI0414450A (pt) derivados de diazabicicloalcano substituìdos como ligandos nos receptores de alfa 7 acetilcolina nicotìnica
DE60232029D1 (de) N-ä1h-indol-5-ylünaphthalin-1-sulphonamid-derivate und verwandte verbindungen als serotonin 5-ht6 rezeptor antagonisten zur behandlung von erkrankungen des zentralen nervensystems
BR9915475A (pt) Derivados da quinolina-4-carboxamida comoantagonistas dos receptores de nk-3 e nk-2
UY26048A1 (es) Derivados de piridopiranoacepinas, su preparacion y su aplicacion terapeutica
BR0010214A (pt) Derivados de ciclotiocarbamato como moduladores de receptores de progesterona
BR9809652A (pt) Derivados de quinolina-4-carboxamida como antagonistas de receptor nk-2 e nk-3
BRPI0411285A (pt) composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios
BRPI0517100A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, método para preparar um composto, composição farmacêutica, e, métodos para tratar um paciente sofrendo de distúrbios e de deficiência
BR0214695A (pt) Derivados de pirazol com anel fundido
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
ATE512142T1 (de) Pyrimidin- und chinazolinderivate als modulatoren der somatostatin-rezeptor aktivität
BRPI0508404A (pt) derivado de (indol-3-il)-heterociclo, composição farmacêutica, uso de um derivado de (indol-3-il)-heterociclo, e método de tratamento da dor
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona
BRPI0414460A (pt) compostos derivados de carboxamida do tipo de amida, composição farmacêutica e respectivo uso
HUP0203603A2 (hu) Új IL-8 receptor antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE60013798D1 (de) Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
BR0308309A (pt) Derivados de isoxazolina amino substituìdo e seu uso como antidepressivos

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11, 13, 24 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.